Literature DB >> 28912145

Dynamic 18F-FDG PET Lymphography for In Vivo Identification of Lymph Node Metastases in Murine Melanoma.

Hannah Lockau1,2,3, Volker Neuschmelting2, Anuja Ogirala1,2, Antoni Vilaseca1,2, Jan Grimm4,2,5,6.   

Abstract

Positron lymphography using 18F-FDG followed by Cerenkov-guided resection of lymph nodes in healthy mice has previously been introduced by our group. Our aim in this study was to further assess the technique's potential beyond merely localizing sentinel lymph nodes. We now aimed to evaluate the potential of positron lymphography to characterize the nodes with respect to their tumor status in order to identify metastatic lymph nodes. We explored whether metastatic nodes could be distinguished from normal nodes via dynamic 18F-FDG lymphography, to then be resected under Cerenkov imaging guidance.
Methods: A murine melanoma cell line highly metastatic to lymph nodes (B16F10) was implanted subcutaneously on the dorsal hind paw of C57 mice while the tumor-free contralateral leg served as an intraindividual control. A model of reactive lymph nodes after concanavalin A challenge served as an additional control to provide nonmalignant inflammatory lymphadenopathy. Dynamic PET/CT imaging was performed immediately after injection of 18F-FDG around the tumor or intracutaneously in the contralateral footpad. Furthermore, PET/CT and Cerenkov studies were performed repeatedly over time to follow the course of metastatic spread. In selected mice, popliteal lymph nodes underwent Cerenkov luminescence imaging. Hematoxylin and eosin staining was done to verify the presence of lymphatic melanoma infiltration.
Results: Positron lymphography using 18F-FDG was successfully performed on tumor-bearing and non-tumor-bearing mice, as well as on controls bearing sites of inflammation; the results clearly identified the sentinel lymph node basin and delineated the lymphatic drainage. Significantly prolonged retention of activity was evident in metastatic nodes as compared with controls without tumor. On the basis of these results, the contrast in detection and identification of metastatic lymph nodes was distinct and could be used for guided lymph node resection, such as by using Cerenkov luminescence imaging. However, retention after 18F-FDG lymphography was also seen in acute inflammatory lymphadenopathy.
Conclusion: In a tumor model, significantly longer retention of the radiotracer during 18F-FDG lymphography was seen in metastatic than nonmetastatic lymph nodes, allowing for differentiation between the two and for selective resection of tumor-bearing nodes using Cerenkov imaging. Inflammation can be better differentiated in a subacute state.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  Cerenkov; melanoma; metastasis; positron lymphography; sentinel lymph node

Mesh:

Substances:

Year:  2017        PMID: 28912145      PMCID: PMC5807531          DOI: 10.2967/jnumed.117.196303

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.

Authors:  Maria I Harrell; Brian M Iritani; Alanna Ruddell
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.

Authors:  P D Shreve
Journal:  Eur J Nucl Med       Date:  1998-03

3.  Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG.

Authors:  Daniel L J Thorek; Diane S Abou; Bradley J Beattie; Rachel M Bartlett; Ruimin Huang; Pat B Zanzonico; Jan Grimm
Journal:  J Nucl Med       Date:  2012-08-07       Impact factor: 10.057

4.  Inflammation-induced lymph node lymphangiogenesis is reversible.

Authors:  Viviane Mumprecht; Filip Roudnicky; Michael Detmar
Journal:  Am J Pathol       Date:  2011-12-23       Impact factor: 4.307

5.  Clinical Cerenkov luminescence imaging of (18)F-FDG.

Authors:  Daniel L J Thorek; Christopher C Riedl; Jan Grimm
Journal:  J Nucl Med       Date:  2013-09-27       Impact factor: 10.057

6.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

7.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

8.  Lymph Node Micrometastases and In-Transit Metastases from Melanoma: In Vivo Detection with Multispectral Optoacoustic Imaging in a Mouse Model.

Authors:  Volker Neuschmelting; Hannah Lockau; Vasilis Ntziachristos; Jan Grimm; Moritz F Kircher
Journal:  Radiology       Date:  2016-05-04       Impact factor: 11.105

9.  A novel aliphatic 18F-labeled probe for PET imaging of melanoma.

Authors:  Hongguang Liu; Shuanglong Liu; Zheng Miao; Han Jiang; Zixin Deng; Xuechuan Hong; Zhen Cheng
Journal:  Mol Pharm       Date:  2013-08-22       Impact factor: 4.939

10.  Histopathological patterns of melanoma metastases in sentinel lymph nodes.

Authors:  C A Murray; W L Leong; D R McCready; D M Ghazarian
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

View more
  4 in total

1.  Positron Lymphography via Intracervical 18F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.

Authors:  Jennifer J Mueller; Lawrence T Dauer; Rajmohan Murali; Alexia Iasonos; Neeta Pandit-Taskar; Nadeem R Abu-Rustum; Jan Grimm
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

2.  Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

Authors:  Benedikt Michael Schaarschmidt; Johannes Grueneisen; Vanessa Stebner; Joachim Klode; Ingo Stoffels; Lale Umutlu; Dirk Schadendorf; Philipp Heusch; Gerald Antoch; Thorsten Dirk Pöppel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-06       Impact factor: 9.236

3.  Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring.

Authors:  Edwin C Pratt; Elizabeth Isaac; Evan P Stater; Guangbin Yang; Ouathek Ouerfelli; Nagavarakishore Pillarsetty; Jan Grimm
Journal:  J Nucl Med       Date:  2020-05-22       Impact factor: 11.082

4.  68Ga-Sienna+ for PET-MRI Guided Sentinel Lymph Node Biopsy: Synthesis and Preclinical Evaluation in a Metastatic Breast Cancer Model.

Authors:  Heli Savolainen; Alessia Volpe; Alkystis Phinikaridou; Michael Douek; Gilbert Fruhwirth; Rafael T M de Rosales
Journal:  Nanotheranostics       Date:  2019-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.